CDK2 and neoplasm: Our previous findings have demonstrated that YTHDF1 facilitates tumor proliferation by stabilizing the translation of CDK2, CDK4, and CyclinD1 on the one hand, on the other hand, it enhances the translation of Keap1, leading to the degradation of Nrf2, thereby sensitizing tumor cell response to cisplatin treatment [11].